BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20820982)

  • 1. Lymph node dissection in the resection of gastric cancer: review of existing evidence.
    Tanizawa Y; Terashima M
    Gastric Cancer; 2010 Aug; 13(3):137-48. PubMed ID: 20820982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer: Current status of lymph node dissection.
    Degiuli M; De Manzoni G; Di Leo A; D'Ugo D; Galasso E; Marrelli D; Petrioli R; Polom K; Roviello F; Santullo F; Morino M
    World J Gastroenterol; 2016 Mar; 22(10):2875-93. PubMed ID: 26973384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node dissection in resectable advanced gastric cancer.
    de Steur WO; Dikken JL; Hartgrink HH
    Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and future perspectives in gastric cancer management.
    Roukos DH
    Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer.
    Hartgrink HH; van de Velde CJ
    J Surg Oncol; 2005 Jun; 90(3):153-65. PubMed ID: 15895448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extent of resection in surgery of stomach carcinoma].
    Sendler A; Etter M; Böttcher K; Siewert JR
    Chirurg; 2002 Apr; 73(4):316-24. PubMed ID: 12063915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of advanced gastric cancer: An evolving issue.
    Marano L; Polom K; Patriti A; Roviello G; Falco G; Stracqualursi A; De Luca R; Petrioli R; Martinotti M; Generali D; Marrelli D; Di Martino N; Roviello F
    Eur J Surg Oncol; 2016 Jan; 42(1):18-27. PubMed ID: 26632080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.
    Douglass HO; Hundahl SA; Macdonald JS; Khatri VP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):133-55. PubMed ID: 17336241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study.
    Ding P; Gao Z; Zheng C; Chen J; Li K; Gao S
    BMC Cancer; 2019 Sep; 19(1):905. PubMed ID: 31510966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infrapyloric lymph node dissection in gastric cancer radical surgery under the guidance of mesenteric anatomy theory].
    Hu JK; Zhang WH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):413-417. PubMed ID: 31104423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive factors for lymph node metastasis in patients with poorly differentiated early gastric cancer].
    Pang BR; Zhu ZL; Li C; Liu WT; KumarSah RD; Yan M; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):446-450. PubMed ID: 31104430
    [No Abstract]   [Full Text] [Related]  

  • 15. Laparoscopy-assisted D2 radical distal gastrectomy for advanced gastric cancer.
    Huang JL; Wei HB; Zheng ZH; Wei B; Chen TF; Huang Y; Guo WP; Hu B
    Dig Surg; 2010; 27(4):291-6. PubMed ID: 20689290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for pancreaticosplenectomy in advanced gastric cancer.
    Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
    Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence.
    Deng J; Liang H; Sun D; Zhang R; Zhan H; Wang X
    Can J Gastroenterol; 2008 Oct; 22(10):835-9. PubMed ID: 18925308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between serosal invasion types and lymph node metastasis after total gastrectomy in gastric cancer and its significance in selection of rational dissection].
    Zhu HT; Zhao YL; Wu YF
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):474-7. PubMed ID: 19950563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?
    Zhang J; Zou S; Luo R; Zhu Z; Wang Z; Xu H; Huang B
    Clin Transl Oncol; 2019 Dec; 21(12):1699-1706. PubMed ID: 30977046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
    Cheong O; Kim BS; Yook JH; Oh ST; Park YK; Ryu SY
    J Surg Oncol; 2008 Dec; 98(7):500-4. PubMed ID: 18770520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.